ConductScience.org, home

Paper908034

Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.

Fidler IJ and 1 other. Cancer Res, 1977. Cited by 92 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Papers, record 908034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/908034

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2021-01-02
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fidler IJI J
2Bucana CC

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Cytotoxicity, ImmunologicMajor topic
LymphocytesMajor topic
MelanomaMajor topic
Animals
Cell Aggregation
Cells, Cultured
Cross Reactions
Histocompatibility Antigens
In Vitro Techniques
Macrophages
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
Neoplasms, Experimental

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
37673917Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy.Nat Commun2023https://conductscience.org/library/papers/37673917PubMed
29399407Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.Oncoimmunology2018https://conductscience.org/library/papers/29399407PubMed
25640991Mouse model for pre-clinical study of human cancer immunotherapy.Curr Protoc Immunol2015https://conductscience.org/library/papers/25640991PubMed
18432774B16 as a mouse model for human melanoma.Curr Protoc Immunol2001https://conductscience.org/library/papers/18432774PubMed
18214474TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.Cancer Immunol Immunother2008https://conductscience.org/library/papers/18214474PubMed
12909737Experimental animal models of pancreatic carcinogenesis and metastasis.Int J Gastrointest Cancer2003https://conductscience.org/library/papers/12909737PubMed
11558630Mouse models of metastatic pancreatic adenocarcinoma.Int J Pancreatol2001https://conductscience.org/library/papers/11558630PubMed
8674280Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs.Clin Exp Metastasis1996https://conductscience.org/library/papers/8674280PubMed
7754628Biology of human colon cancer metastasis.World J Surg1995https://conductscience.org/library/papers/7754628PubMed
6965227Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6965227PubMed
6616441The selective nature of metastasis.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6616441PubMed
6352013Organ specific metastasis with special reference to avian systems.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6352013PubMed
6231096Immunology of metastasis. Can the immune response cope with disseminated tumor?Cancer Metastasis Rev1983https://conductscience.org/library/papers/6231096PubMed
3829045Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3829045PubMed
3730254Radiation response of proliferating and quiescent subpopulations isolated from multicellular spheroids.Br J Cancer1986https://conductscience.org/library/papers/3730254PubMed
3350842Mechanism of liver-specific metastatic tumor spread in a murine tumor model.J Cancer Res Clin Oncol1988https://conductscience.org/library/papers/3350842PubMed
3319276Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.Cancer Metastasis Rev1987https://conductscience.org/library/papers/3319276PubMed
3129225Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.Clin Exp Metastasis1988https://conductscience.org/library/papers/3129225PubMed
1380062Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes.J Exp Med1992https://conductscience.org/library/papers/1380062PubMed
311336The mechanism of T-cell mediated cytotoxicity. VI. T-cell projections and their role in target cell killing.Immunology1979https://conductscience.org/library/papers/311336PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/908034

GET https://conductscience.org/api/papers/v1/908034/authors